Qi601: A Postbiotic Solution for Microplastic Mitigation

A novel postbiotic supplement, Qi601, developed by Quorum Innovations, shows potential in mitigating microplastic absorption by binding to plastic particles. The supplement utilizes the rough cell walls of heat-killed Limosilactobacillus fermentum to capture microplastics, preventing their accumulation in human cells. This breakthrough offers a proactive approach to reducing the internal burden of environmental microplastics, which have been linked to cardiovascular and neurological health risks. The research team, led by Eva Berkes, demonstrated that Qi601 can bind up to 92 percent of nanoplastics in simulated digestive fluids and reduce intracellular plastic accumulation by 43 percent in laboratory settings. A human trial involving chewing gum confirmed a significant reduction in free-floating plastic particles in saliva, dropping from 2152 to 185 particles when the supplement was introduced. While these findings are promising, experts like Martin Wagner caution that the supplement does not address inhaled microplastics or the continuous nature of environmental exposure. The study serves as a foundational step in microplastic mitigation, though further research is required to confirm its efficacy in the complex environment of the human gut and its ability to facilitate the excretion of captured particles. For practical application, this supplement represents a potential tool for individuals seeking to reduce their internal microplastic load. However, it should be viewed as a complementary strategy rather than a replacement for source-reduction efforts, such as minimizing plastic consumption and exposure in daily life.